vs

Side-by-side financial comparison of enCore Energy Corp. (EU) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $12.4M, roughly 1.8× enCore Energy Corp.). NEKTAR THERAPEUTICS runs the higher net margin — -165.4% vs -173.9%, a 8.5% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-65.0M).

Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

EU vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.8× larger
NKTR
$21.8M
$12.4M
EU
Higher net margin
NKTR
NKTR
8.5% more per $
NKTR
-165.4%
-173.9%
EU
More free cash flow
EU
EU
$72.1M more FCF
EU
$7.2M
$-65.0M
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EU
EU
NKTR
NKTR
Revenue
$12.4M
$21.8M
Net Profit
$-21.5M
$-36.1M
Gross Margin
37.9%
Operating Margin
-135.9%
-126.9%
Net Margin
-173.9%
-165.4%
Revenue YoY
-25.3%
Net Profit YoY
-596.9%
EPS (diluted)
$-0.11
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EU
EU
NKTR
NKTR
Q4 25
$12.4M
$21.8M
Q3 25
$8.9M
$11.8M
Q2 25
$3.7M
$11.2M
Q1 25
$18.2M
$10.5M
Q4 24
$29.2M
Q3 24
$24.1M
Q2 24
$23.5M
Q1 24
$21.6M
Net Profit
EU
EU
NKTR
NKTR
Q4 25
$-21.5M
$-36.1M
Q3 25
$-4.8M
$-35.5M
Q2 25
$-6.3M
$-41.6M
Q1 25
$-24.2M
$-50.9M
Q4 24
$7.3M
Q3 24
$-37.1M
Q2 24
$-52.4M
Q1 24
$-36.8M
Gross Margin
EU
EU
NKTR
NKTR
Q4 25
37.9%
Q3 25
43.8%
Q2 25
30.8%
Q1 25
-0.1%
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
EU
EU
NKTR
NKTR
Q4 25
-135.9%
-126.9%
Q3 25
-158.2%
-268.6%
Q2 25
-526.1%
-324.2%
Q1 25
-85.7%
-425.8%
Q4 24
49.2%
Q3 24
-142.4%
Q2 24
-211.9%
Q1 24
-163.7%
Net Margin
EU
EU
NKTR
NKTR
Q4 25
-173.9%
-165.4%
Q3 25
-53.7%
-301.3%
Q2 25
-172.7%
-372.2%
Q1 25
-132.9%
-486.4%
Q4 24
24.9%
Q3 24
-153.6%
Q2 24
-222.9%
Q1 24
-170.1%
EPS (diluted)
EU
EU
NKTR
NKTR
Q4 25
$-0.11
$-4.67
Q3 25
$-0.03
$-1.87
Q2 25
$-0.03
$-2.95
Q1 25
$-0.13
$-0.24
Q4 24
$-2.07
Q3 24
$-2.66
Q2 24
$-3.76
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EU
EU
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$52.4M
$15.1M
Total DebtLower is stronger
$110.0M
Stockholders' EquityBook value
$229.2M
$89.8M
Total Assets
$430.4M
$280.4M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EU
EU
NKTR
NKTR
Q4 25
$52.4M
$15.1M
Q3 25
$91.9M
$41.0M
Q2 25
$26.9M
$43.0M
Q1 25
$29.7M
$38.9M
Q4 24
$44.3M
Q3 24
$30.1M
Q2 24
$27.9M
Q1 24
$48.6M
Total Debt
EU
EU
NKTR
NKTR
Q4 25
$110.0M
Q3 25
$109.3M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EU
EU
NKTR
NKTR
Q4 25
$229.2M
$89.8M
Q3 25
$248.6M
$85.1M
Q2 25
$264.7M
$-24.2M
Q1 25
$267.9M
$13.7M
Q4 24
$60.7M
Q3 24
$48.9M
Q2 24
$79.7M
Q1 24
$126.7M
Total Assets
EU
EU
NKTR
NKTR
Q4 25
$430.4M
$280.4M
Q3 25
$441.9M
$301.3M
Q2 25
$359.4M
$207.5M
Q1 25
$362.6M
$256.2M
Q4 24
$303.9M
Q3 24
$308.0M
Q2 24
$343.3M
Q1 24
$396.0M
Debt / Equity
EU
EU
NKTR
NKTR
Q4 25
0.48×
Q3 25
0.44×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EU
EU
NKTR
NKTR
Operating Cash FlowLast quarter
$12.9M
$-65.0M
Free Cash FlowOCF − Capex
$7.2M
$-65.0M
FCF MarginFCF / Revenue
57.8%
-298.0%
Capex IntensityCapex / Revenue
46.7%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.0M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EU
EU
NKTR
NKTR
Q4 25
$12.9M
$-65.0M
Q3 25
$-20.3M
$-48.8M
Q2 25
$-9.9M
$-45.7M
Q1 25
$-7.7M
$-49.1M
Q4 24
$-46.2M
Q3 24
$-43.9M
Q2 24
$-37.7M
Q1 24
$-47.9M
Free Cash Flow
EU
EU
NKTR
NKTR
Q4 25
$7.2M
$-65.0M
Q3 25
$-26.3M
$-48.9M
Q2 25
$-14.1M
$-45.8M
Q1 25
$-11.7M
$-49.1M
Q4 24
$-46.6M
Q3 24
$-44.6M
Q2 24
$-37.9M
Q1 24
$-48.0M
FCF Margin
EU
EU
NKTR
NKTR
Q4 25
57.8%
-298.0%
Q3 25
-296.6%
-414.5%
Q2 25
-385.2%
-409.6%
Q1 25
-64.1%
-469.0%
Q4 24
-159.9%
Q3 24
-184.9%
Q2 24
-161.3%
Q1 24
-222.0%
Capex Intensity
EU
EU
NKTR
NKTR
Q4 25
46.7%
0.1%
Q3 25
68.0%
1.0%
Q2 25
115.1%
0.3%
Q1 25
21.7%
0.0%
Q4 24
1.6%
Q3 24
2.8%
Q2 24
0.8%
Q1 24
0.7%
Cash Conversion
EU
EU
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-6.36×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons